Cargando…

COVID-19: general overview, pharmacological options and ventilatory support strategies

The novel coronavirus called “Severe Acute Respiratory Syndrome Coronavirus 2” (SARS-CoV-2) caused an outbreak in December 2019, starting from the Chinese city of Wuhan, in the Hubei province, and rapidly spreading to the rest of the world. Consequently, the World Health Organization (WHO) declared...

Descripción completa

Detalles Bibliográficos
Autores principales:	Menzella, Francesco, Matucci, Andrea, Vultaggio, Alessandra, Barbieri, Chiara, Biava, Mirella, Scelfo, Chiara, Fontana, Matteo, Facciolongo, Nicola Cosimo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	PAGEPress Publications, Pavia, Italy 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7662457/ https://www.ncbi.nlm.nih.gov/pubmed/33282284 http://dx.doi.org/10.4081/mrm.2020.708

Ejemplares similares

Pharmacologicaltreatment of COVID-19: lights and shadows
por: Menzella, Francesco, et al.
Publicado: (2020)

Severe refractory asthma: current treatment options and ongoing research
por: Menzella, Francesco, et al.
Publicado: (2018)

Pneumonia and Invasive Pneumococcal Diseases: The Role of Pneumococcal Conjugate Vaccine in the Era of Multi-Drug Resistance
por: Scelfo, Chiara, et al.
Publicado: (2021)

Immunological Aspects Related to Viral Infections in Severe Asthma and the Role of Omalizumab
por: Menzella, Francesco, et al.
Publicado: (2021)

Anti-IL5 Therapies for Severe Eosinophilic Asthma: Literature Review and Practical Insights
por: Menzella, Francesco, et al.
Publicado: (2020)

Real world effectiveness of benralizumab on respiratory function and asthma control
por: Menzella, Francesco, et al.
Publicado: (2021)

Efficacy and steroid-sparing effect of benralizumab: has it an advantage over its competitors?
por: Menzella, Francesco, et al.
Publicado: (2019)

A Dangerous Consequence of the Recent Pandemic: Early Lung Fibrosis Following COVID-19 Pneumonia – Case Reports
por: Scelfo, Chiara, et al.
Publicado: (2020)

Precision Medicine in Targeted Therapies for Severe Asthma: Is There Any Place for “Omics” Technology?
por: Galeone, Carla, et al.
Publicado: (2018)

Towards precision medicine: The application of omics technologies in asthma management
por: Scelfo, Chiara, et al.
Publicado: (2018)

Efficacy and Safety of Omalizumab Treatment Over a 16-Year Follow-Up: When a Clinical Trial Meets Real-Life
por: Menzella, Francesco, et al.
Publicado: (2022)

Lung "holes" after cryobiopsy: a case report
por: Piro, Roberto, et al.
Publicado: (2021)

A Real-World Evaluation of Clinical Outcomes of Biologicals and Bronchial Thermoplasty for Severe Refractory Asthma (BIOTERM)
por: Menzella, Francesco, et al.
Publicado: (2021)

Successful treatment with benralizumab in a patient with eosinophilic granulomatosis with polyangiitis refractory to mepolizumab
por: Menzella, Francesco, et al.
Publicado: (2021)

Efficacy of tocilizumab in patients with COVID-19 ARDS undergoing noninvasive ventilation
por: Menzella, Francesco, et al.
Publicado: (2020)

Bronchial thermoplasty in severe asthma: a real-world study on efficacy and gene profiling
por: Facciolongo, Nicola, et al.
Publicado: (2022)

Innovative treatments for severe refractory asthma: how to choose the right option for the right patient?
por: Menzella, Francesco, et al.
Publicado: (2017)

Diagnosis and Pattern Identification of Intrathoracic Malignant Melanoma Metastasis: A Retrospective Single Center Analysis
por: Fontana, Matteo, et al.
Publicado: (2022)

May 2020: Is It Always COVID-19 No Matter What?
por: Livrieri, Francesco, et al.
Publicado: (2020)

The pharmacoeconomics of the state-of-the-art drug treatments for asthma: a systematic review
por: Menzella, Francesco, et al.
Publicado: (2021)

Pleural mesothelioma: When echo‐endoscopy (EUS‐B‐FNA) leads to diagnosis in a minimally invasive way
por: Piro, Roberto, et al.
Publicado: (2021)

Bronchial thermoplasty and the role of airway smooth muscle: are we on the right direction?
por: Menzella, Francesco, et al.
Publicado: (2017)

Predictive Factors of Ventilatory Support in Chest Trauma
por: Fattori, Silvia, et al.
Publicado: (2021)

Mechanisms of Action of Ig Preparations: Immunomodulatory and Anti-Inflammatory Effects
por: Matucci, Andrea, et al.
Publicado: (2015)

The use of intravenous versus subcutaneous monoclonal antibodies in the treatment of severe asthma: a review
por: Matucci, Andrea, et al.
Publicado: (2018)

The clinical profile of benralizumab in the management of severe eosinophilic asthma
por: Menzella, Francesco, et al.
Publicado: (2016)

Safety and Diagnostic Accuracy of the Transnasal Approach for Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration (EBUS-TBNA)
por: Piro, Roberto, et al.
Publicado: (2023)

Is IgE or eosinophils the key player in allergic asthma pathogenesis? Are we asking the right question?
por: Matucci, Andrea, et al.
Publicado: (2018)

Long-term benefits of omalizumab in a patient with severe non-allergic asthma
por: Menzella, Francesco, et al.
Publicado: (2011)

Heat-induced necrosis after bronchial thermoplasty: a new concern?
por: Menzella, Francesco, et al.
Publicado: (2018)

Acute respiratory failure as presentation of late-onset Pompe disease complicating the diagnostic process as a labyrinth: a case report
por: Menzella, Francesco, et al.
Publicado: (2018)

Clinical usefulness of mepolizumab in severe eosinophilic asthma
por: Menzella, Francesco, et al.
Publicado: (2016)

Promising Treatment Options for Axial Spondyloarthritis: An Overview of Experimental Pharmacological Agents
por: Tahir, Hasan, et al.
Publicado: (2021)

Eosinophilic infiltrate in a patient with severe Legionella pneumonia as a levofloxacin-related complication: a case report
por: Facciolongo, Nicola, et al.
Publicado: (2010)

“Neurologist's contribution to the diagnosis of sine materia respiratory insufficiency: case report”
por: Carbonelli, Cristiano, et al.
Publicado: (2012)

Near-fatal asthma responsive to mepolizumab after failure of omalizumab and bronchial thermoplasty
por: Menzella, Francesco, et al.
Publicado: (2017)

Strategies Targeting Type 2 Inflammation: From Monoclonal Antibodies to JAK-Inhibitors
por: Matucci, Andrea, et al.
Publicado: (2021)

Oxygen Therapy and Ventilatory Support
por: Gu, Wan-Jie, et al.
Publicado: (2017)

Pediatric Mechanical Circulatory Support: Pathophysiology of Pediatric Hemostasis and Available Options
por: Giorni, Chiara, et al.
Publicado: (2021)

Daytime noninvasive ventilatory support for patients with ventilatory pump failure: a narrative review
por: Banfi, Paolo, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_dbknfqnrinh9aalrrlklpgqbms